A half-century-old diabetes drug appears to help treat bipolar disorder by reversing patients' insulin resistance, according to a small-scale clinical trial.
Jul 27, 2022
0
22
In type 1 diabetes, the body develops immune cells that target pancreatic beta cells, which play a critical role in the production and secretion of insulin. One of the earliest targets of this immune response is a specific ...
Jul 25, 2022
0
130
A new study from ICES and The Hospital for Sick Children (SickKids) finds no overall difference in the relative rate of childhood diabetes in Ontario during the first 18 months of the COVID-19 pandemic.
Jul 25, 2022
0
13
Black adolescents who lived in poverty and were less optimistic about the future showed accelerated aging in their immune cells and were more likely to have elevated insulin resistance at ages 25-29, researchers have found.
Jul 25, 2022
0
58
Sodium–glucose cotransporter 2 (SGLT2) inhibitors, such as empagliflozin, dapagliflozin, canagliflozin and ertugliflozin, have been game changers in the treatment of type 2 diabetes, but their potential for closing the ...
Jul 25, 2022
0
28
A new study published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]) finds that following a time-restricted eating (TRE) protocol, which limits food intake to a maximum 10-hour ...
Jul 25, 2022
0
17
A world-first study by Monash University, in Melbourne, Australia has discovered a pathway to the regeneration of insulin in pancreatic stem cells, a major breakthrough toward new therapies to treat Type 1 and Type 2 diabetes.
Jul 22, 2022
0
215
Cystic fibrosis is well-known for attacking the lungs through thick blockages of mucus, but those with the condition often also develop diabetes because of the way cystic fibrosis can affect the pancreas. Since diabetes has ...
Jul 21, 2022
0
5
Alyssa Hasty, Cornelius Vanderbilt Professor of Molecular Physiology and Biophysics, specializes in immunometabolism, specifically on the role that the immune system plays in obesity and metabolic disease. Recent work from ...
Jul 20, 2022
0
4
Fucoidan, a kind of sulfated polysaccharide present in brown algae, is considered as a promising therapeutic agent because of its multiple bioactivities.
Jul 20, 2022
0
4
